Related Articles

• The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice
• Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase
• Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway
• Sitagliptin attenuates inflammatory responses in lipopolysaccharide‑stimulated cardiomyocytes via nuclear factor‑κB pathway inhibition
• Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice